FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it has closed its previously announced rights offering. The Company received valid subscriptions for all of shares purchasable in the rights offering, including shares subscribed for by certain of the Company’s stockholders in the exercise of their over-subscription rights, at a subscription price of $8.50 per share. The Company issued the shares purchased in the rights offering to the purchasers on June 25, 2009. After the closing of the rights offering, the Company sold 343,406 shares of its common stock to Novo A/S, a stockholder of the Company, in a private placement. The purchase price of such shares was $8.50 per share, the same purchase price of the shares sold in the rights offering.
